RPS6 and leiomyosarcoma: In our experimental conditions, we observed a similar effect; trabectedin treatment increases the phosphorylation of the ribosomal protein S6, an effect that is avoided by treating leiomyosarcoma cells with mTOR inhibitor rapamycin.